Asset Details
Do you wish to reserve the book?
Clinical development success rates for investigational drugs
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical development success rates for investigational drugs
Do you wish to request the book?
Clinical development success rates for investigational drugs
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical development success rates for investigational drugs
2014
Overview
The most comprehensive survey of clinical success rates across the drug industry to date shows productivity may be even lower than previous estimates. This article aims to measure clinical development success rates across the industry with a view to strengthening benchmarking metrics for drug development. The study is the largest and most recent of its kind, examining success rates of 835 drug developers, including biotech companies as well as specialty and large pharmaceutical firms from 2003 to 2011. Success rates for over 7,300 independent drug development paths are analyzed by clinical phase, molecule type, disease area and lead versus nonlead indication status.
Publisher
Nature Publishing Group US,Nature Publishing Group
